Many leading pharma and biotechs have invested in messenger RNA (mRNA) technology to develop COVID-19 vaccines and are now exploring their potential in other disease areas (Figure 1). The success ...

Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight ...

Harrisvaccines has been awarded a $1.114 million contract from the U.S. Department of Homeland Security Science and Technology Directorate to develop an RNA Particle (RP) vaccine to potentially ...

Human cases in the US are on the rise and the virus is turning up in cows and dairy products. Luckily, we have some vaccines ...

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...

We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a ...

Technology is constantly evolving, which means that websites – and the way they are structured – evolve. So do the devices we use to access search engines. A web search can be voice activated ...

Traditional mRNA-based approaches have shown immense potential, particularly in rapid vaccine deployment and gene replacement therapies. Building upon this foundation, self-amplifying RNA (saRNA) ...

During the Belgian Economic Mission to Brazil, a historic Memorandum of Understanding (MoU) was signed between the Brazilian ...